High-throughput stem cell bioprocess design - environmental influences on pluripotent stem cell expansion and differentiation

高通量干细胞生物工艺设计——环境对多能干细胞扩增和分化的影响

• 批准号: 239083-2011
• 负责人: Kallos, Michael
• 金额: $ 2.91万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=514431
• 关键词: throughput; stem; cell; bioprocess; design

Regenerative medicine is a rapidly growing billion dollar multidisciplinary field at the intersection of medicine, engineering and science. It aims to create living, functional tissues that can repair or replace damaged, diseased or aging tissues or organs. Stem cells are critical to the success of regenerative medicine therapies, and what are needed are technologies to bridge the gap between basic biology and the clinical application of stem cells. The proposed research program will accelerate the development of these technologies, specifically targeting a reliable, reproducible way to grow stem cells to build tissues. The research will focus on pluripotent stem cells as they have the potential to generate any cell type in the body, i.e. large numbers of specialized (differentiated) cells. They can be derived from the inner cell mass of an early development blastocyst (embryonic stem cells) or from adult cells such as skin cells that are modified by the addition of key factors to be pluripotent (induced pluripotent stem cells). One of the major stumbling blocks on the road to effective regenerative medicine treatments is the limited number of available donor cells, and the small-scale, labour-intensive methods for culturing and differentiating them. The primary objective of the proposed research is to develop engineering methods and technology for efficiently growing human pluripotent stem cells in computer-controlled bioreactors. First, the effect of key bioreactor conditions (such as oxygen level) and the transport of nutrients will be examined for individual stem cell clusters and entire bioreactors. Second, new technology will be developed to accelerate the development of bioprocesses through the use of multiple smaller bioreactors as high-throughput tools to study many conditions quickly. The long term outcomes include innovative bioprocess designs, as well as critical knowledge of how output parameters (i.e. cell type, behaviour) are influenced by cell processing parameters (i.e. bioreactor oxygen level). This is fundamentally necessary for the regulatory approval and clinical application of stem cell technologies, including the generation and transplantation of cells/tissues for the treatment of human ailments (i.e. stroke, Parkinson's disease, diabetes).

再生医学是一个快速增长的数十亿美元的多学科领域，在医学，工程和科学的交叉点。 它旨在创造活的功能组织，可以修复或替换受损，患病或老化的组织或器官。 干细胞对于再生医学疗法的成功至关重要，我们需要的是弥合基础生物学和干细胞临床应用之间差距的技术。 拟议的研究计划将加速这些技术的发展，特别是针对一种可靠的，可重复的方式来培养干细胞来构建组织。这项研究将集中在多能干细胞上，因为它们有潜力在体内产生任何类型的细胞，即大量的特化（分化）细胞。 它们可以来源于早期发育囊胚的内细胞团（胚胎干细胞）或通过添加关键因子而被修饰为多能的成体细胞（诱导多能干细胞）。有效的再生医学治疗方法的主要障碍之一是可用供体细胞的数量有限，以及培养和分化它们的小规模，劳动密集型方法。这项研究的主要目的是开发工程方法和技术，在计算机控制的生物反应器中有效地培养人类多能干细胞。首先，将检查单个干细胞簇和整个生物反应器的关键生物反应器条件（如氧气水平）和营养物质运输的影响。其次，将开发新技术，通过使用多个较小的生物反应器作为高通量工具来快速研究许多条件，从而加速生物过程的发展。长期成果包括创新的生物工艺设计，以及输出参数（即细胞类型，行为）如何受到细胞加工参数（即生物反应器氧气水平）影响的关键知识。这对于干细胞技术的监管批准和临床应用，包括用于治疗人类疾病（即中风、帕金森病、糖尿病）的细胞/组织的产生和移植，是根本必要的。